A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.

NCT00784719 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

327

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndromes

Interventions

DRUG: CP-690,550
DRUG: CP-690,550
DRUG: CP-690,550
DRUG: CP-690,550
DRUG: Cyclosporine
DRUG: CP-690,550 Vehicle

Sponsor

Pfizer